Dextran conjugates in drug delivery

Bibliography

• Suflet DM, Chitanu GC, Desbrieres J. Phosphorylated polysaccharides. 2. Synthesis and properties of phosphorylated dextran. Carbohydr Polym 2010;82(4):1271-7
   Web of Science ®Google Scholar
• Purama RK, Goswami P, Khan AT, Goyal A. Structural analysis and properties of dextran produced by Leuconostoc mesenteroides NRRL B-640. Carbohydr Polym 2009;76(1):30-5
   Web of Science ®Google Scholar
• Can HK, Denizli BK, Guner A, Rzaev ZMO. Effect of functional crosslinking agents on preparation and swelling properties of dextran hydrogels. Carbohydr Polym 2005;59(1):51-6
   Web of Science ®Google Scholar
• Harboe E, Johansen M, Larsen C. Macromolecular pro-drugs. VI. Coupling of naproxen to dextrans and in vitro characterization of the conjugates. Farm Sci Ed 1988;16:73-85
   Google Scholar
• Lukyanov AN, Sawant RM, Hartner WC, Torchilin VP. PEGylated dextran as long-circulating pharmaceutical carrier. J Biomater Sci Polym Ed 2004;15(5):621-30
   PubMed Web of Science ®Google Scholar
• Williams AS, Taylor G. Synthesis, characterization and release of cromoglycate from dextran conjugates. Int J Pharm 1982;83(1-3):233-9
   Google Scholar
• Weiner BZ, Tahan M, Zilkha A. Polymers containing phenethylamines. J Med Chem 1972;15:410-13
   PubMed Web of Science ®Google Scholar
• Bocher M, Boldicke T, Kieß M, Bilitewski U. Synthesis of mono- and bifunctional peptide–dextran conjugates for the immobilization of peptide antigens on ELISA plates: properties and application. J Immun Methods 1997;208(2):191-202
   PubMed Web of Science ®Google Scholar
• Axen R, Porath J, Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogens halides. Nature 1967;214:1302-4
   PubMed Web of Science ®Google Scholar
• Lapasin R, Pricl S. Rheology of Industrial Polysaccharides: Theory and Applications. Aspen Publication; New York: 1995
   Google Scholar
• Edman P, Ekman B, Sjoholm I. Immobilization of proteins in microspheres of biodegradable polyacyldextran. J Pharm Sci 1980;69(7):838-42
   PubMed Web of Science ®Google Scholar
• Brondsted H, Anderson C, Hovgaard L. Crosslinked dextran—a new capsule material for colon targeting of drugs. J Control Release 1998;53(1-3):7-13
   PubMed Web of Science ®Google Scholar
• Dogan AK, Gumusderelioglu M, Aksoz E. Controlled release of EGF and bFGF from dextran hydrogels in vitro and in vivo. J Biomed Mater Res B Appl Biomater 2005;74(1):504-10
   PubMedGoogle Scholar
• Kim SH, Won CY, Chu CC. Synthesis and characterization of dextran based hydrogels prepared by photocrosslinking. Carbohydr Polym 1999;40(3):183-90
   Web of Science ®Google Scholar
• Kim SH, Won CY, Chu CC. Synthesis and characterization of dextran-maleic acid based hydrogel. J Biomed Mater Res 1999;46(2):160-70
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chu CC. Biodegradable dextran–polylactide hydrogel networks: their swelling, morphology and the controlled release of indomethacin. J Biomed Mater Res 2002;59(2):318-28
   PubMed Web of Science ®Google Scholar
• Bartkowiak A, Jezierska I, Spychai T. An EPR study of polysaccharide copper (II) complexes in composite dextran/epichlorohydrin gels. Polym Bull 1998;41(2):199-206
   Web of Science ®Google Scholar
• Jin R, Moreira Teixeira LS, Dijkstra PJ, Enzymatically crosslinked dextran-tyramine hydrogels as injectable scaffolds for cartilage tissue engineering. Tissue Eng Part A 2010;16(8):2429-40
   PubMed Web of Science ®Google Scholar
• Jin R, Hiemstra C, Zhong Z, Feijen J. Enzyme-mediated fast in situ formation of hydrogels from dextran-tyramine conjugates. Biomater 2007;28(18):2791-800
   PubMed Web of Science ®Google Scholar
• Feeney M, Giannuzzo M, Paolicelli P, Casadei MA. Hydrogels of dextran containing nonsteroidal anti-inflammatory drugs as pendant agents. Drug Deliv 2007;14(2):87-93
   PubMed Web of Science ®Google Scholar
• Porfire AS, Zabaleta V, Gamazo C, Influence of dextran on the bioadhesive properties of poly(anhydride) nanoparticles. Int J Pharm 2010;390(1):37-44
   PubMed Web of Science ®Google Scholar
• Jeong YI, Kim DH, Chung CW, Doxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer. Int J Nanomed 2011;6:1415-27
   PubMed Web of Science ®Google Scholar
• Bang JY, Song CE, Kim C, Cytotoxicity of amphotericin B-incorporated polymeric micelles composed of poly(DL-lactide-co-glycolide)/dextran graft copolymer. Arch Pharm Res 2008;31(11):1463-9
   PubMed Web of Science ®Google Scholar
• Du YZ, Weng Q, Yuan H, Hu FQ. Synthesis and antitumor activity of stearate-g-dextran micelles for intracellular doxorubicin delivery. ACS Nano 2010;4(11):6894-902
   PubMed Web of Science ®Google Scholar
• Afifi H, da Silva MA, Nouvel C, Associative networks of cholesterol-modified dextran with short and long micelles. Soft Matter 2011;7:4888-99
   Web of Science ®Google Scholar
• Sun H, Guo B, Li X, Shell-sheddable micelles based on dextran-ss-poly(epsilon-caprolactone) diblock copolymer for efficient intracellular release of doxorubicin. Biomacromolecules 2010;11(4):848-54
   PubMed Web of Science ®Google Scholar
• QiaoYing W, HongYing S, ChunChao X, Amphiphilic dextran/magnetite nanocomposites as magnetic resonance imaging probes. Chin Sci Bull 2009;54(17):2925-33
   Web of Science ®Google Scholar
• Zhang YL, Dou XW, Jin T. Synthesis and self-assembly behavior of amphiphilic diblock copolymer dextran-block-poly(epsilon-caprolactone) (DEX-b-PCL) in aqueous media. eXPRESS Polymer Letters 2010;4(10):599-610
   Web of Science ®Google Scholar
• Qiu F, Feng J, Wu DQ, Nanosized micelles self-assembled from amphiphilic dextran graft methoxypolyethylene glycol/poly(epsilon-caprolactone) copolymers. Eur Polym J 2009;45(4):1024-31
   Web of Science ®Google Scholar
• Jeong YI, Chung KD, Choi KC. Doxorubicin release from self-assembled nanoparticles of deoxycholic acid-conjugated dextran. Arch Pharm Res 2011;34(1):159-67
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Hassanzadeh F, Sadeghi H, Synthesis and characterization of folate-targeted micellar nanocapsules of dextran/retinoic acid. Proceed 2nd Int Conf Nanotechnol: Fundamentals and Applications; 28 – 29 July 2011; Ottawa, Ontario, Canada
   Google Scholar
• Varshosaz J, Hassanzadeh F, Sadeghi H, Folate-targeted micellar nanocapsules of dextran/retinoic acid for doxorubicin delivery in acute leukemia. Proceed 4th Int Conf Nanostructures (ICNS4); 12 – 14 March 2012; Kish Island, I.R. Iran
   Google Scholar
• Mu M, Pan X, Yao P, Jiang M. Acidic solution properties of beta-casein-graft-dextran copolymer prepared through Maillard reaction. J Colloid Interface Sci 2006;301(1):98-106
   PubMed Web of Science ®Google Scholar
• Etzel MR, Bund T. Monoliths for the purification of whey protein-dextran conjugates. J Chromatogr A 2011;1218(17):2445-50
   PubMed Web of Science ®Google Scholar
• Mehvar R. Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: pharmacokinetic and pharmacodynamic perspectives. Curr Pharm Biotechnol 2003;4(5):283-302
   PubMedGoogle Scholar
• Moore A, Marecos E, Bogdanov A Jr, Weissleder R. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 2000;214(2):568-74
   PubMed Web of Science ®Google Scholar
• Fujita T, Yasuda Y, Takakura Y, Tissue distribution of 111In-labeled uricase conjugated with charged dextrans and polyethylene glycol. J Pharmacobiodyn 1991;14(11):623-9
   PubMedGoogle Scholar
• Mumtaz S, Bachhawat BK. Conjugation of proteins and enzymes with hydrophilic polymers and their applications. Indian J Biochem Biophys 1991;28(5-6):346-51
   PubMed Web of Science ®Google Scholar
• Zhao Q, Tolmachev V, Carlsson J, Effects of dextranation on the pharmacokinetics of short peptides. A PET study on mEGF. Bioconjug Chem 1999;10(6):938-46
   PubMed Web of Science ®Google Scholar
• Jiang D, Salem AK. Optimized dextran-polyethylenimine conjugates are efficient non-viral vectors with reduced cytotoxicity when used in serum containing environments. Int J Pharm 2011; [Epub ahead of print] doi:10.1016/j.ijpharm.2011.10.032
   Google Scholar
• Goodwin AP, Tabakman SM, Welsher K, Phospholipid-dextran with a single coupling point: a useful amphiphile for functionalization of nanomaterials. J Am Chem Soc 2009;131(1):289-96
   PubMed Web of Science ®Google Scholar
• Kopp AF, Laniado M, Dammann F, MR imaging of the liver with resovist: safety, efficacy, and pharmacodynamic properties. Radiologia 1997;204(3):749-56
   Google Scholar
• Kobeiter H, Georgiades CS, Leakakos T, Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field. Anticancer Res 2007;27(2):755-60
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Fahling H, Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993;9(1):51-68
   PubMed Web of Science ®Google Scholar
• Moroz P, Jones SK, Winter J, Targeting liver tumors with hyperthermia: ferromagnetic embolization in a rabbit liver tumor model. J Surg Oncol 2001;78(1):22-49
   PubMed Web of Science ®Google Scholar
• Moroz P, Metcalf C, Gray BN. Histologic analysis of liver tissue following hepatic arterial infusion of ferromagnetic particles in a rabbit tumour model. Biomater 2003;16(3):455-64
   Google Scholar
• Motoyama J, Yamashita N, Morino T, Hyperthermic treatment of DMBA-induced rat mammary cancer using magnetic nanoparticles. Biomagn Res Technol 2008;6(2):1-6
   PubMedGoogle Scholar
• Takamatsu S, Matsui O, Gabata T, Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits. Radiat Med 2008;26(4):179-87
   PubMedGoogle Scholar
• Wada S, Yue L, Tazawa K, New local hyperthermia using dextran magnetite complex (DM) for oral cavity: experimental study in normal hamster tongue. Oral Dis 2001;7(3):192-5
   PubMed Web of Science ®Google Scholar
• Mitsumori M, Hiraoka M, Shibata T, Development of intra-arterial hyperthermia using a dextran-magnetite complex. Int J Hyperthermia 1994;10(6):785-93
   PubMed Web of Science ®Google Scholar
• Mitsumori M, Hiraoka M, Shibata T, Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors. Hepatogastroenterology 1996;43(12):1431-7
   PubMed Web of Science ®Google Scholar
• Sonoda A, Nitta N, Ohta S, Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging. Eur J Radiol 2009;71(3):570-5
   PubMed Web of Science ®Google Scholar
• Konishi M, Tabata Y, Kariya M, In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release 2005;103(1):7-19
   PubMed Web of Science ®Google Scholar
• Hilger I, Hergt R, Kaiser WA. Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc Nanobiotechnol 2005;152(1):33-9
   PubMedGoogle Scholar
• Sonoda A, Nitta N, Nitta-Seko A, Complex comprised of dextran magnetite and conjugated cisplatin exhibiting selective hyperthermic and controlled-release potential. Int J Nanomed 2010;5:499-504
   PubMed Web of Science ®Google Scholar
• Zhang J, Misra RD. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticle carrier and drug release response. Acta Biomater 2007;3(6):838-50
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Ahmadi F, Emami J, Microencapsulation of budesonide with dextran by spray drying technique for colon-targeted delivery: an in vitro/in vivo evaluation in induced colitis in rat. J Microencapsul 2011;28(1):62-73
   PubMed Web of Science ®Google Scholar
• Ahmadi F, Varshosaz J, Emami J, Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats. Drug Deliv 2011;18(2):122-30
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Ahmadi F, Emami J, Colon delivery of budesonide using solid dispersion in dextran for the treatment and secondary prevention of ulcerative colitis in rat. Int J Prev Med 2010;1(2):115-23
   Google Scholar
• Varshosaz J, Emami J, Tavakoli N, Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis. Int J Pharm 2009;365(1-2):69-76
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Fassihi A, Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats. Int J Colorectal Dis 2010;25(10):1159-65
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Emami J, Ahmadi F, Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis. J Drug Target 2011;19(2):140-53
   PubMed Web of Science ®Google Scholar
• Pang YN, Zhang Y, Zhang ZR. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting. World J Gastroenterol 2002;8(5):913-17
   PubMed Web of Science ®Google Scholar
• Zhou SY, Mei QB, Liu L, Characteristics of drug-release in vitro of different dextran-dexamethasone conjugates. Yao Xue Xue Bao 2003;38(5):388-91
   PubMedGoogle Scholar
• Larsen C, Jensen BH, Olesen HP. Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig. Acta Pharm Nord 1991;3(2):71-6
   PubMedGoogle Scholar
• Shrivastava PK, Shrivastava SK. Dextran carrier macromolecule for colon specific delivery of celecoxib. Curr Drug Deliv 2010;7(2):144-51
   PubMedGoogle Scholar
• Ahmad S, Tester RF, Corbett A, Karkalas J. Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis. Carbohydr Res 2006;341(16):2694-701
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim IH, Kim J, Evaluation of dextran-flufenamic acid ester as a polymeric colon-specific prodrug of flufenamic acid, an anti-inflammatory drug, for chronotherapy. J Drug Target 2011;19(5):336-43
   PubMed Web of Science ®Google Scholar
• Vyas S, Trivedi P, Chaturvedi SC. Ketorolac-dextran conjugates: synthesis, in vitro and in vivo evaluation. Acta Pharm 2007;57(4):441-50
   PubMedGoogle Scholar
• Shrivastava SK, Jain DK, Trivedi P. Dextrans-potential polymeric drug carriers for flurbiprofen. Pharmazie 2003;58(6):389-91
   PubMed Web of Science ®Google Scholar
• Giannuzzo M, Corrente F. Feeney M, et al. pH-Sensitive hydrogels of dextran: synthesis, characterization and in vivo studies. J Drug Target 2008;16(9):649-59
   PubMed Web of Science ®Google Scholar
• Francis MF, Lavoie L, Winnik FM, Leroux JC. Solubilization of cyclosporin A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles. Eur J Pharm Biopharm 2003;56(3):337-46
   PubMed Web of Science ®Google Scholar
• Tu J, Zhong S, Li P. Studies on acyclovir–dextran conjugate: synthesis and pharmacokinetics. Drug Dev Ind Pharm 2004;30(9):959-65
   PubMed Web of Science ®Google Scholar
• Nakamura J, Nakajima N, Matsumura K, Hyon SH. Water-soluble taxol conjugates with dextran and targets tumor cells by folic acid immobilization. Anticancer Res 2010;30(3):903-9
   PubMed Web of Science ®Google Scholar
• Bisht S, Maitra A. Dextran–doxorubicin/chitosan nanoparticles for solid tumor therapy. Nanomed Nanobiotechnol 2009;1(4):415-25
   Web of Science ®Google Scholar
• Mitra S, Gaur U, Ghosh PC, Maitra AN. Tumour targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 2001;74(1-3):317-23
   PubMed Web of Science ®Google Scholar
• Zhang J, Luo M, Zhou Y, Zhang JR. Anti-human IgG-dextran-adriamycin conjugate for immunotargeting of S180 sarcoma: effects on the tumor weight and survival time of the tumor-bearing mice. Nan Fang Yi Ke Da Xue Xue Bao 2008;28(4):646-8
   PubMedGoogle Scholar
• Dang W, Colvin HB, Saltzman WM. Covalent coupling of methotrexate to dextran enhances the penetration of cytotoxicity into a tissue-like matrix. Cancer Res 1994;54(7):1729-35
   PubMed Web of Science ®Google Scholar
• Nomura T, Saikawa A, Morita S, Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection. J Control Release 1998;52(3):239-52
   PubMed Web of Science ®Google Scholar
• Hao AJ, Deng YJ, Suo XB, Cao YH. Synthesis and characteristics of the fluorouracil-dextran conjugates. Pharmazie 2006;61(5):489-90
   PubMed Web of Science ®Google Scholar
• Nakashima M, Ichinose K, Kanematsu T, In vitro characteristics and in vivo plasma disposition of cisplatin conjugated with oxidized and dicarboxymethylated dextrans. Biol Pharm Bull 1999;22(7):756-61
   PubMed Web of Science ®Google Scholar
• Lam W, Leung CH, Chan HL, Fong WF. Toxicity and DNA binding of dextran-doxorubicin conjugates in multidrug-resistant KB-V1 cells: optimization of dextran size. Anticancer Drugs 2000;11(5):377-84
   PubMed Web of Science ®Google Scholar
• Guu JA, Hsiue GH, Juang TM. Synthesis and biological properties of antitumor-active conjugates of ADR with dextran. J Biomater Sci Polym Ed 2002;13(10):1135-51
   PubMed Web of Science ®Google Scholar
• Mehvar R, Robinson MA, Reynolds JM. Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats. J Pharm Sci 1994;83(10):1495-9
   PubMed Web of Science ®Google Scholar
• Penugonda S, Agarwal HK, Parang K, Mehvar R. Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats. J Pharm Sci 2010;99(3):1626-37
   PubMed Web of Science ®Google Scholar
• Melton RG, Wiblin CN, Baskerville A, Covalent linkage of carboxypeptidase G2 to soluble dextrans–II. In vivo distribution and fate of conjugates. Biochem Pharmacol 1987;36(1):113-21
   PubMed Web of Science ®Google Scholar
• Melton RG, Wiblin CN, Foster RL, Sherwood RF. Covalent linkage of carboxypeptidase G2 to soluble dextrans–I. Properties of conjugates and effects on plasma persistence in mice. Biochem Pharmacol 1987;36(1):105-12
   PubMed Web of Science ®Google Scholar
• Kaneo Y, Fujihara Y, Tanaka T, Intrahepatic delivery of glutathione by conjugation to dextran. Pharm Res 1989;6(12):1025-31
   PubMed Web of Science ®Google Scholar
• Takakura Y, Fujita T, Hashida M, Sezaki H. Disposition characteristics of macromolecules in tumor-bearing mice. Pharm Res 1990;7:339-46
   PubMed Web of Science ®Google Scholar
• Nishida K, Tonegawa C, Nakane S, Effect of electric charge on the hepatic uptake of macromolecules in the rat liver. Int J Pharm 1990;65:7-17
   Google Scholar
• Nishida K, Mihara K, Takino T, Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver. Pharm Res 1991;8:437-44
   PubMed Web of Science ®Google Scholar
• Lake JR, Licko V, Van Dyke RW, Scharschmidt BF. Biliary secretion of fluid-phase markers by the isolated perfused rat liver. Role of transcellular vesicular transport. J Clin Invest 1985;76:676-84
   PubMed Web of Science ®Google Scholar
• Vansteenkiste S, Schacht E, Duncan R, Fate of glycosylated dextrans after in vivo administration. J Control Release 1991;16:91-100
   Web of Science ®Google Scholar
• Nishikawa M, Kamijo A, Fujita T, Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting. Pharm Res 1993;10(9):1253-61
   PubMed Web of Science ®Google Scholar
• Schechter B, Chen L, Arnon R, Wilchek M. Organ selective delivery using a tissue-directed sreptavidin-biotin system: targeting 5-fluorouridine via TNP-streptavidin. J Drug Target 1999;6(5):337-48
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Yamashita F, Takakura Y, Demonstration of the receptor-mediated hepatic uptake of dextran in mice. J Pharm Pharmacol 1992;44(5):396-401
   PubMed Web of Science ®Google Scholar
• De Carvalho PB, Ramos DCC, Cotrim PC, Ferreira EI. Synthesis and in vitro evaluation of potential anti-leishmanial targeted drugs of pyrimethamine. J Pharm Sci 2003;92(10):2109-16
   PubMed Web of Science ®Google Scholar
• Yasukawa T, Kimura H, Tabata Y, Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination. Invest Ophthalmol Vis Sci 2002;43(3):842-8
   PubMed Web of Science ®Google Scholar
• Roseeuw E, Coessens V, Balazuc AM, Degradation, and antimicrobial properties of targeted macromolecular prodrugs of norfloxacin. Antimicrob Agents Chemother 2003;47(11):3435-41
   PubMed Web of Science ®Google Scholar
• Danhauser-Riedl S, Hausmann E, Schick HD, Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD). Invest New Drugs 1993;11(2-3):187-95
   PubMed Web of Science ®Google Scholar